News

$1.8 million to pioneer mRNA vaccine against UTIs

The UNSW RNA Institute is part of a $1.8 million MRFF funded collaboration to develop an mRNA vaccine for urinary tract infections (UTIs).

UNSW partners with Therapeutics Innovation Australia to boost RNA ecosystem

UNSW Sydney is partnering with Therapeutics Innovation Australia (TIA) as part of a new network established to support RNA research, development and commercialisation in Australia.

UNSW and UCSI Malaysia forge partnership for global health research collaboration

UNSW and UCSI are poised to tackle some of the most pressing human health challenges, leveraging the wealth of expertise at the UNSW RNA Institute, and UCSI’s Centre of Excellence for Research, Value Innovation and Entrepreneurship (CERVIE).

Livestock vaccine manufactured in NSW for first time by UNSW RNA Institute

The NSW Government pilot project to fast-track an mRNA vaccine for border disease virus (BDV) has been successfully manufactured for the first time in NSW by the UNSW RNA Institute.

UNSW chemist honoured by Australian Academy of Science for decades-long achievements

Professor Justin Gooding has been recognised for his innovative work, including commercialising one of the most used analytical medical devices in the world, the blood glucose meter.

$40m research-industry grants for international collaboration

The Federal Government invests $40m into growing Australia’s global presence in science, with RNA vaccines and therapies as a focus area.

UNSW celebrates $119m funding to support RNA research across 14 universities

RNA science has significant potential to treat cancer genetic and autoimmune diseases – making critical contributions toward advancing human health.

He almost became a farmer in Iceland. Now, he's leading RNA development in Australia

UNSW Sydney professor Pall Thordarson shares the chemical reaction that took him from working on a farm in Iceland to running the first RNA institute in Australia.

Green light for universal COVID-19 vaccine project

A universal vaccine that could bring an end to the COVID-19 pandemic is now in development at the Garvan Institute of Medical Research.

$2m funds COVID research at UNSW including new RNA treatment

Researchers will investigate treatment measures for COVID-19 infection and the aerosol transmission of SARS-COV-2.

Universal siRNA COVID-19 treatment shows promise in the lab

If proven effective in future clinical trials, these therapeutics will be a key tool in the fight against COVID-19.